Noscapine Prevents Rotenone-Induced Neurotoxicity: Involvement of Oxidative Stress, Neuroinflammation and Autophagy Pathways.


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
30 Jul 2021
Historique:
received: 03 05 2021
revised: 23 07 2021
accepted: 26 07 2021
entrez: 7 8 2021
pubmed: 8 8 2021
medline: 18 9 2021
Statut: epublish

Résumé

Parkinson's disease is characterized by the loss of dopaminergic neurons in substantia nigra pars compacta (SNpc) and the resultant loss of dopamine in the striatum. Various studies have shown that oxidative stress and neuroinflammation plays a major role in PD progression. In addition, the autophagy lysosome pathway (ALP) plays an important role in the degradation of aggregated proteins, abnormal cytoplasmic organelles and proteins for intracellular homeostasis. Dysfunction of ALP results in the accumulation of α-synuclein and the loss of dopaminergic neurons in PD. Thus, modulating ALP is becoming an appealing therapeutic intervention. In our current study, we wanted to evaluate the neuroprotective potency of noscapine in a rotenone-induced PD rat model. Rats were administered rotenone injections (2.5 mg/kg, i.p.,) daily followed by noscapine (10 mg/kg, i.p.,) for four weeks. Noscapine, an iso-qinulinin alkaloid found naturally in the Papaveraceae family, has traditionally been used in the treatment of cancer, stroke and fibrosis. However, the neuroprotective potency of noscapine has not been analyzed. Our study showed that administration of noscapine decreased the upregulation of pro-inflammatory factors, oxidative stress, and α-synuclein expression with a significant increase in antioxidant enzymes. In addition, noscapine prevented rotenone-induced activation of microglia and astrocytes. These neuroprotective mechanisms resulted in a decrease in dopaminergic neuron loss in SNpc and neuronal fibers in the striatum. Further, noscapine administration enhanced the mTOR-mediated p70S6K pathway as well as inhibited apoptosis. In addition to these mechanisms, noscapine prevented a rotenone-mediated increase in lysosomal degradation, resulting in a decrease in α-synuclein aggregation. However, further studies are needed to further develop noscapine as a potential therapeutic candidate for PD treatment.

Identifiants

pubmed: 34361780
pii: molecules26154627
doi: 10.3390/molecules26154627
pmc: PMC8348109
pii:
doi:

Substances chimiques

Neuroprotective Agents 0
alpha-Synuclein 0
Rotenone 03L9OT429T
Noscapine 8V32U4AOQU
Catalase EC 1.11.1.6
Superoxide Dismutase EC 1.15.1.1
mTOR protein, rat EC 2.7.1.1
Ribosomal Protein S6 Kinases, 70-kDa EC 2.7.11.1
TOR Serine-Threonine Kinases EC 2.7.11.1
Dopamine VTD58H1Z2X

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : United Arab Emirates University
ID : UPAR31M234

Références

J Cereb Blood Flow Metab. 2016 Sep;36(9):1481-507
pubmed: 27323783
Neurotoxicology. 2015 Jan;46:101-16
pubmed: 25514659
Mol Neurobiol. 2017 Sep;54(7):4866-4878
pubmed: 27514753
Exp Neurobiol. 2018 Apr;27(2):77-87
pubmed: 29731673
Biomed Pharmacother. 2015 Aug;74:101-10
pubmed: 26349970
Clin Cancer Res. 2004 Aug 1;10(15):5187-201
pubmed: 15297423
Neurobiol Aging. 2014 May;35(5):1116-24
pubmed: 24360742
Autophagy. 2008 Oct;4(7):917-9
pubmed: 18708765
Cell Mol Life Sci. 2000 Dec;57(13-14):1894-908
pubmed: 11215516
J Neurochem. 2001 Jan;76(2):637-40
pubmed: 11208927
ACS Chem Neurosci. 2012 Dec 19;3(12):1063-72
pubmed: 23259041
Mol Med Rep. 2018 Jan;17(1):131-137
pubmed: 29115479
Exp Neurol. 2008 Jan;209(1):5-11
pubmed: 17603039
Int J Mol Sci. 2018 Jul 31;19(8):
pubmed: 30065205
Exp Neurol. 2012 Oct;237(2):318-34
pubmed: 22750327
Eur J Neurosci. 2000 Aug;12(8):3073-7
pubmed: 10971650
Ageing Int. 2017;42(3):274-289
pubmed: 28890585
PLoS One. 2015 Dec 23;10(12):e0145310
pubmed: 26698860
Neurosci Lett. 1994 Jan 3;165(1-2):208-10
pubmed: 8015728
Trends Mol Med. 2011 Dec;17(12):734-42
pubmed: 21890410
Adv Neurobiol. 2016;12:415-96
pubmed: 27651267
Trends Neurosci. 2010 Dec;33(12):541-9
pubmed: 20947179
J Neurosci. 2006 Sep 27;26(39):9996-10005
pubmed: 17005863
Neurosci Bull. 2010 Feb;26(1):66-76
pubmed: 20101274
J Neurochem. 1990 Dec;55(6):2142-5
pubmed: 2121905
Eur J Clin Pharmacol. 2003 Nov;59(8-9):579-81
pubmed: 14517705
Acta Pharmacol Toxicol (Copenh). 1967;25(3):333-8
pubmed: 5630490
Toxicol Lett. 2003 Apr 4;139(2-3):135-51
pubmed: 12628749
Curr Top Med Chem. 2017;17(2):174-188
pubmed: 27237331
Expert Opin Ther Targets. 2018 Oct;22(10):823-832
pubmed: 30185079
FASEB J. 2002 Nov;16(13):1826-8
pubmed: 12223445
Continuum (Minneap Minn). 2016 Apr;22(2 Dementia):435-63
pubmed: 27042903
Autophagy. 2018;14(5):845-861
pubmed: 29433359
J Cell Sci. 2007 Dec 1;120(Pt 23):4155-66
pubmed: 18032788
Toxicol Sci. 2015 Jan;143(1):81-96
pubmed: 25304210
Sci Rep. 2016 Aug 24;6:32206
pubmed: 27553905
J Neurochem. 2005 Jul;94(1):215-25
pubmed: 15953364
Neuroreport. 2017 Oct 18;28(15):996-1007
pubmed: 28902711
Cell Cycle. 2014;13(9):1400-12
pubmed: 24626186
Essays Biochem. 2016 Oct 15;60(2):173-180
pubmed: 27744333
Molecules. 2019 Jun 10;24(11):
pubmed: 31185705
Front Aging Neurosci. 2017 Jun 08;9:176
pubmed: 28642697
J Neurol Sci. 1997 May 29;148(2):181-6
pubmed: 9129114
Eur J Clin Pharmacol. 1979;16(6):393-7
pubmed: 527635
Autophagy. 2016 Oct 2;12(10):1849-1863
pubmed: 27485532
Lancet Neurol. 2018 Nov;17(11):939-953
pubmed: 30287051
Front Mol Neurosci. 2014 Mar 14;7:18
pubmed: 24672426
Oncotarget. 2017 Aug 10;8(45):78677-78690
pubmed: 29108257
Prog Neurobiol. 2012 Nov;99(2):128-48
pubmed: 22980037
Cell Signal. 2014 Dec;26(12):2694-701
pubmed: 25173700
Biochim Biophys Acta. 2012 May;1820(5):595-600
pubmed: 21846491
Brain Pathol. 2003 Oct;13(4):473-81
pubmed: 14655753
Epilepsia. 2007 Apr;48(4):617-30
pubmed: 17386056
Sci Rep. 2018 Jan 23;8(1):1385
pubmed: 29362387
Trends Neurosci. 2017 Jun;40(6):358-370
pubmed: 28527591
Proc Natl Acad Sci U S A. 1989 Feb;86(4):1398-400
pubmed: 2919185
Free Radic Biol Med. 2018 Feb 1;115:80-91
pubmed: 29080843
Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7659-63
pubmed: 9636206
Neurosci Lett. 1994 Oct 24;180(2):147-50
pubmed: 7700568
J Neuroinflammation. 2010 Aug 11;7:45
pubmed: 20701773
Neurobiol Dis. 2016 Jan;85:262-274
pubmed: 25766679
BMC Neurosci. 2016 Aug 22;17(1):58
pubmed: 27549180
Acta Neuropathol. 2000 Jan;99(1):14-20
pubmed: 10651022
Antioxidants (Basel). 2020 Aug 13;9(8):
pubmed: 32823544
Histol Histopathol. 1997 Jan;12(1):25-31
pubmed: 9046040
Cell Tissue Res. 2018 Jul;373(1):111-135
pubmed: 29516217
Mol Neurobiol. 2012 Dec;46(3):639-61
pubmed: 22899187
Cell Death Dis. 2019 Feb 12;10(2):133
pubmed: 30755581
Neurochem Int. 2013 Apr;62(5):803-19
pubmed: 23291248
J Neurosci. 1999 May 1;19(9):3440-7
pubmed: 10212304
J Neurol Sci. 1996 May;137(2):120-3
pubmed: 8782165
Neurogenetics. 2007 Apr;8(2):83-94
pubmed: 17211632
PLoS One. 2009;4(5):e5515
pubmed: 19436756
Neuromolecular Med. 2017 Mar;19(1):1-10
pubmed: 27263112
J Cell Sci. 2013 Apr 15;126(Pt 8):1713-9
pubmed: 23641065
Front Aging Neurosci. 2018 Apr 17;10:109
pubmed: 29719505
Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):467-72
pubmed: 11756682
Neurochem Res. 2013 Jan;38(1):201-7
pubmed: 23117422
J Neurochem. 1989 Sep;53(3):692-7
pubmed: 2760616
Pharmacol Rep. 2006 Jul-Aug;58(4):568-70
pubmed: 16963805

Auteurs

Richard L Jayaraj (RL)

Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain 17666, United Arab Emirates.

Rami Beiram (R)

Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain 17666, United Arab Emirates.

Sheikh Azimullah (S)

Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain 17666, United Arab Emirates.

Nagoor Meeran M F (NM)

Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain 17666, United Arab Emirates.

Shreesh K Ojha (SK)

Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain 17666, United Arab Emirates.

Abdu Adem (A)

College of Medicine and Health Sciences, Khalifa University, Abu Dhabi 127788, United Arab Emirates.

Fakhreya Yousuf Jalal (FY)

Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain 17666, United Arab Emirates.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH